Walgreen’s (WAG )
is the largest drugstore operator in the US ,
operating over 7700 drugstores. The company has grown earnings and dividends 12-16%
annually over the past ten years, earning a 15-16% return on capital. Like most
retail firms, WAG experienced an earnings
hiccup in 2009; but it should be able to sustain an above average earnings
growth rate in the future because:
(1) the +60 year
old population, which is the largest user of drugs, is growing faster than any
other segment of the population; in addition, the improvement in the quality of
drugs for the maintenance of medical conditions should drive enhance revenue
growth,
(2) renewal of
its contract with Express Scripts,
(3) acquisitions,
(4) an
aggressive stock buy back program.
Negatives:
(1) it must
still earn back customer losses resulting form Express Scripts dispute,
(2) a highly
competitive industry,
(3) the sluggish
economy impacts consumer spending that in turn hampers its growth,
Statistical Summary
Stock Dividend Payout # Increases
Yield Growth Rate Ratio
Since 2002
Debt/ EPS Down Net Value Line
Equity ROE Since 2002 Margin
Rating
*few of the companies in this
industry pay a dividend
Chart
Note:
WAG stock made good initial progress off its
March 2009 low, quickly surpassing the downtrend off its August 2007 high
(straight red line) and the November 2008 trading high (green line). Long term the stock is in a trading range (blue
lines). Intermediate term, it has struggled
to hold an uptrend (purple lines). The
wiggly red line is the 50 day moving average.
The Aggressive Growth Portfolio owns a full position in WAG . The upper boundary of its Buy
Value Range
is $27; the lower boundary of its Sell
Half Range
is $43.
10/12
No comments:
Post a Comment